{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":5,"total":312,"mapped":5},"pagination":{"has_next":true,"next_token":"-1[]P37231,1,P37231,177,3][P03372,1,P03372,121,1]["},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P11511","source":"P11511|Aromatase","targets":["3EQM|Crystal structure of human placental aromatase cytochrome P450 in complex with androstenedione|X-RAY DIFFRACTION|2.9|Homo sapiens|0|OXIDOREDUCTASE","3S79|Human placental aromatase cytochrome P450 (CYP19A1) refined at 2.75 angstrom|X-RAY DIFFRACTION|2.75|Homo sapiens|0|OXIDOREDUCTASE","3S7S|Crystal structure of human placental aromatase complexed with breast cancer drug exemestane|X-RAY DIFFRACTION|3.21|Homo sapiens|0|Oxidoreductase/Oxidoreductase Inhibitor","4GL5|Structure of human placental aromatase complexed with designed inhibitor HDDG029 (compound 4)|X-RAY DIFFRACTION|3.48|Homo sapiens|0|Oxidoreductase/Oxidoreductase Inhibitor","4GL7|Structure of human placental aromatase complexed with designed inhibitor HDDG046 (compound 5)|X-RAY DIFFRACTION|3.9|Homo sapiens|0|Oxidoreductase/Oxidoreductase inhibitor","4KQ8|Structure of Recombinant Human Cytochrome P450 Aromatase|X-RAY DIFFRACTION|3.29|Homo sapiens|0|OXIDOREDUCTASE","5JKV|HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL|X-RAY DIFFRACTION|2.75|Homo sapiens|0|OXIDOREDUCTASE","5JKW|HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE|X-RAY DIFFRACTION|3|Homo sapiens|0|OXIDOREDUCTASE","5JL6|HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2|X-RAY DIFFRACTION|3|Homo sapiens|0|OXIDOREDUCTASE","5JL7|HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3|X-RAY DIFFRACTION|3.1|Homo sapiens|0|OXIDOREDUCTASE","5JL9|HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4|X-RAY DIFFRACTION|3.1|Homo sapiens|0|OXIDOREDUCTASE"]},{"input":"P21802","source":"P21802|Fibroblast growth factor receptor 2","targets":["1DJS|LIGAND-BINDING PORTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1|X-RAY DIFFRACTION|2.4|Homo sapiens|0|HORMONE/GROWTH FACTOR/RECEPTOR","1E0O|CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX|X-RAY DIFFRACTION|2.8|HOMO SAPIENS|0|GROWTH FACTOR","1EV2|CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)|X-RAY DIFFRACTION|2.2|Homo sapiens|0|GROWTH FACTOR/GROWTH FACTOR RECEPTOR","1GJO|The FGFr2 tyrosine kinase domain|X-RAY DIFFRACTION|2.4|HOMO SAPIENS|0|TRANSFERASE","1II4|CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2|X-RAY DIFFRACTION|2.7|Homo sapiens|0|GROWTH FACTOR/GROWTH FACTOR RECEPTOR","1IIL|CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2|X-RAY DIFFRACTION|2.3|Homo sapiens|0|GROWTH FACTOR/GROWTH FACTOR RECEPTOR","1NUN|Crystal Structure Analysis of the FGF10-FGFR2b Complex|X-RAY DIFFRACTION|2.9|Homo sapiens|0|HORMONE/GROWTH FACTOR/MEMBRANE PROTEIN","1OEC|FGFr2 kinase domain|X-RAY DIFFRACTION|2.4|HOMO SAPIENS|0|TRANSFERASE","1WVZ|Solution Structure of the D2 Domain of the Fibroblast Growth Factor|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2FDB|Crystal Structure of Fibroblast growth factor (FGF)8b in complex with FGF Receptor (FGFR) 2c|X-RAY DIFFRACTION|2.28|Homo sapiens|0|HORMONE/GROWTH FACTOR/TRANSFERASE","2PSQ|Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE","2PVF|Crystal Structure of Tyrosine Phosphorylated Activated FGF Receptor 2 (FGFR2) Kinase Domain in Complex with ATP Analog and Substrate Peptide|X-RAY DIFFRACTION|1.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","2PVY|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","2PWL|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE","2PY3|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","2PZ5|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation Responsible for Pfeiffer Syndrome|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE","2PZP|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE","2PZR|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K641R Mutation Responsible for Pfeiffer Syndrome|X-RAY DIFFRACTION|3|Homo sapiens|0|TRANSFERASE","2Q0B|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSFERASE","3B2T|Structure of phosphotransferase|X-RAY DIFFRACTION|1.8|Homo sapiens|0|TRANSFERASE","3CAF|Crystal Structure of hFGFR2 D2 Domain|X-RAY DIFFRACTION|1.96|Homo sapiens|0|TRANSFERASE","3CLY|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domains Trapped in Trans-Phosphorylation Reaction|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE","3CU1|Crystal Structure of 2:2:2 FGFR2D2:FGF1:SOS complex|X-RAY DIFFRACTION|2.6|Homo sapiens|0|Transferase/Hormone","3DAR|Crystal structure of D2 domain from human FGFR2|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","3EUU|Crystal structure of the FGFR2 D2 domain|X-RAY DIFFRACTION|2.34|Homo sapiens|0|TRANSFERASE","3OJ2|Crystal structure of FGF1 complexed with the ectodomain of FGFR2b harboring the A172F Pfeiffer syndrome mutation|X-RAY DIFFRACTION|2.2|Homo sapiens|0|Cytokine/Signaling Protein","3OJM|Crystal Structure of FGF1 complexed with the ectodomain of FGFR2b harboring P253R Apert mutation|X-RAY DIFFRACTION|2.1|Homo sapiens|0|Cytokine/Signaling Protein","3RI1|Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069|X-RAY DIFFRACTION|2.1|Homo sapiens|0|Transferase/Transferase Inhibitor","4J23|Low resolution crystal structure of the FGFR2D2D3/FGF1/SR128545 complex|X-RAY DIFFRACTION|3.882|Homo sapiens|0|SIGNALING PROTEIN/transferase","4J95|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.|X-RAY DIFFRACTION|2.3767|Homo sapiens|0|TRANSFERASE","4J96|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.|X-RAY DIFFRACTION|2.2972|Homo sapiens|0|TRANSFERASE","4J97|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.|X-RAY DIFFRACTION|2.5482|Homo sapiens|0|TRANSFERASE","4J98|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.|X-RAY DIFFRACTION|2.3067|Homo sapiens|0|TRANSFERASE","4J99|Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.|X-RAY DIFFRACTION|1.8474|Homo sapiens|0|TRANSFERASE","4WV1|Crystal structure of the FGFR2 D2 domain in complex with Fab 2B.1.3|X-RAY DIFFRACTION|2.362|Homo sapiens|0|TRANSFERASE/IMMUNE SYSTEM","5EG3|Crystal Structure of the Activated FGF Receptor 2 (FGFR2) Kinase Domain in complex with the cSH2 domain of Phospholipase C gamma (PLCgamma)|X-RAY DIFFRACTION|2.606|Homo sapiens; Rattus norvegicus|0|Transferase/Hydrolase","5UGL|Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation|X-RAY DIFFRACTION|1.861|Homo sapiens|0|TRANSFERASE","5UGX|Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation|X-RAY DIFFRACTION|2.349|Homo sapiens|0|TRANSFERASE","5UHN|Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation|X-RAY DIFFRACTION|2.909|Homo sapiens|0|TRANSFERASE","5UI0|Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation|X-RAY DIFFRACTION|2.05|Homo sapiens|0|TRANSFERASE","6AGX|The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold|X-RAY DIFFRACTION|2.95|Homo sapiens|0|TRANSFERASE/INHIBITOR","6LVK|Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative|X-RAY DIFFRACTION|2.29|Homo sapiens|0|TRANSFERASE","6LVL|Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative|X-RAY DIFFRACTION|2.98|Homo sapiens|0|TRANSFERASE","6V6Q|Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657|X-RAY DIFFRACTION|2.46|Homo sapiens|0|TRANSFERASE","7KIA|Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19|X-RAY DIFFRACTION|2.22|Homo sapiens|0|SIGNALING PROTEIN","7KIE|Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3|X-RAY DIFFRACTION|2.47|Homo sapiens|0|SIGNALING PROTEIN","7OZY|FGFR2 kinase domain (residues 461-763) in complex with 38.|X-RAY DIFFRACTION|2.28|Homo sapiens|0|TRANSFERASE","8E1X|FGFR2 kinase domain in complex with a Pyrazolo[1,5-a]pyrimidine analog (Compound 29)|X-RAY DIFFRACTION|2.68|Homo sapiens|0|STRUCTURAL PROTEIN","8H75|FGFR2 in complex with YJ001|X-RAY DIFFRACTION|3.75|Homo sapiens|0|TRANSFERASE","8STG|Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations|X-RAY DIFFRACTION|3.79|Homo sapiens|0|TRANSFERASE/INHIBITOR","8SWE|FGFR2 Kinase Domain Bound to Reversible Inhibitor Cmpd 3|X-RAY DIFFRACTION|2.24|Homo sapiens|0|ONCOPROTEIN","8U1F|FGFR2 Kinase Domain Bound to Irreversible Inhibitor Cmpd 10|X-RAY DIFFRACTION|3.33|Homo sapiens|0|Transferase/Inhibitor","8W2X|TAS-120 covalent structure with FGFR2|X-RAY DIFFRACTION|2.98|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","8W38|TAS-120 covalent structure with FGFR2 molecular brake mutant|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","8W3B|TAS-120 covalent structure with FGFR2 molecular brake mutant|X-RAY DIFFRACTION|2.23|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","8W3D|TAS-120 covalent structure with FGFR2 molecular brake mutant|X-RAY DIFFRACTION|2.04|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","9U3N|Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with compound LC-F2-01|X-RAY DIFFRACTION|3.25|Homo sapiens|0|TRANSFERASE","9U7E|FGFR2 kinase domain with a macrocyclic compound 8g|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","9U7S|FGFR2 kinase domain with a macrocyclic compound 8r|X-RAY DIFFRACTION|1.99|Homo sapiens|0|TRANSFERASE"]},{"input":"P31749","source":"P31749|RAC-alpha serine/threonine-protein kinase","targets":["1H10|HIGH RESOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF PROTEIN KINASE B/AKT BOUND TO INS(1,3,4,5)-TETRAKISPHOPHATE|X-RAY DIFFRACTION|1.4|HOMO SAPIENS|0|TRANSFERASE","1UNP|Crystal structure of the pleckstrin homology domain of PKB alpha|X-RAY DIFFRACTION|1.65|HOMO SAPIENS|0|TRANSFERASE","1UNQ|High resolution crystal structure of the Pleckstrin Homology Domain Of Protein Kinase B/Akt Bound To Ins(1,3,4,5)-Tetrakisphophate|X-RAY DIFFRACTION|0.98|HOMO SAPIENS|0|TRANSFERASE","1UNR|Crystal structure of the PH domain of PKB alpha in complex with a sulfate molecule|X-RAY DIFFRACTION|1.25|HOMO SAPIENS|0|TRANSFERASE","2UVM|Structure of PKBalpha PH domain in complex with a novel inositol headgroup surrogate, benzene 1,2,3,4-tetrakisphosphate|X-RAY DIFFRACTION|1.94|HOMO SAPIENS|0|TRANSFERASE","2UZR|A transforming mutation in the pleckstrin homology domain of AKT1 in cancer (AKT1-PH_E17K)|X-RAY DIFFRACTION|1.94|Homo sapiens|0|TRANSFERASE","2UZS|A transforming mutation in the pleckstrin homology domain of AKT1 in cancer (AKT1-PH_E17K)|X-RAY DIFFRACTION|2.46|Homo sapiens|0|TRANSFERASE","3CQU|Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor|X-RAY DIFFRACTION|2.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","3CQW|Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","3MV5|Crystal structure of Akt-1-inhibitor complexes|X-RAY DIFFRACTION|2.47|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","3MVH|Crystal structure of Akt-1-inhibitor complexes|X-RAY DIFFRACTION|2.01|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","3O96|Crystal Structure of Human AKT1 with an Allosteric Inhibitor|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE","3OCB|Akt1 kinase domain with pyrrolopyrimidine inhibitor|X-RAY DIFFRACTION|2.7|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","3OW4|Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors|X-RAY DIFFRACTION|2.6|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/TRANSFERASE inhibitor","3QKK|Spirochromane Akt Inhibitors|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/TRANSFERASE INHIBITOR","3QKL|Spirochromane Akt Inhibitors|X-RAY DIFFRACTION|1.9|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/TRANSFERASE INHIBITOR","3QKM|Spirocyclic sulfonamides as AKT inhibitors|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4EJN|Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide|X-RAY DIFFRACTION|2.19|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4EKK|Akt1 with AMP-PNP|X-RAY DIFFRACTION|2.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","4EKL|Akt1 with GDC0068|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE","4GV1|PKB alpha in complex with AZD5363|X-RAY DIFFRACTION|1.49|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5KCV|Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE/INHIBITOR","6BUU|Crystal structure of AKT1 (aa 144-480) with a bisubstrate|X-RAY DIFFRACTION|2.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","6CCY|Crystal structure of Akt1 in complex with a selective inhibitor|X-RAY DIFFRACTION|2.18|Homo sapiens|0|TRANSFERASE/INHIBITOR","6HHF|Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSFERASE","6HHG|Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","6HHH|Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE","6HHI|Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 30b|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSFERASE","6HHJ|Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","6NPZ|Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate|X-RAY DIFFRACTION|2.12|Homo sapiens|0|TRANSFERASE","6S9W|Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","6S9X|Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSFERASE","7APJ|Structure of autoinhibited Akt1 reveals mechanism of PIP3-mediated activation|X-RAY DIFFRACTION|2.05|Danio rerio; Homo sapiens; Lama glama|0|SIGNALING PROTEIN","7MYX|Crystal structure of the PH domain (R86A) of Akt1|X-RAY DIFFRACTION|1.39|Homo sapiens|0|SIGNALING PROTEIN","7NH4|Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","7NH5|Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 6|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSFERASE","8JOW|Crystal structure of rabbit antibody with phosphorylated peptide bound|X-RAY DIFFRACTION|1.4|Oryctolagus cuniculus; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","8UVY|Structure of AKT1(E17K) with compound 3|X-RAY DIFFRACTION|2.11|Homo sapiens; Lama glama|0|TRANSFERASE/INHIBITOR","8UW2|Structure of AKT1(E17K) with compound 3 (zinc-free)|X-RAY DIFFRACTION|2.2|Homo sapiens; Lama glama|0|TRANSFERASE/INHIBITOR","8UW7|Structure of AKT1(WT) with compound 3|X-RAY DIFFRACTION|1.972|Homo sapiens; Lama glama|0|TRANSFERASE/INHIBITOR","8UW9|Structure of AKT1(E17K) with compound 4|X-RAY DIFFRACTION|1.9|Homo sapiens; Lama glama|0|TRANSFERASE/INHIBITOR","8ZPU|Crystal structure of the anti-phosphorylated peptide C7 scFv antibody with peptide bound|X-RAY DIFFRACTION|2.8|Oryctolagus cuniculus; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM"]},{"input":"P37231","source":"P37231|Peroxisome proliferator-activated receptor gamma","targets":["1FM6|THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1FM9|THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES.|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1I7I|CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242|X-RAY DIFFRACTION|2.35|Homo sapiens|0|TRANSCRIPTION","1K74|The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and RXRalpha ligand binding domains respectively bound with GW409544 and 9-cis retinoic acid and co-activator peptides.|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1KNU|LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST|X-RAY DIFFRACTION|2.5|Homo sapiens|0|DNA BINDING PROTEIN","1NYX|Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with an agonist|X-RAY DIFFRACTION|2.65|Homo sapiens|0|TRANSCRIPTION","1PRG|LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA|X-RAY DIFFRACTION|2.2|Homo sapiens|0|GENE REGULATION","1RDT|Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer|X-RAY DIFFRACTION|2.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR","1WM0|PPARgamma in complex with a 2-BABA compound|X-RAY DIFFRACTION|2.9|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/SIGNALING PROTEIN","1ZEO|Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSCRIPTION","1ZGY|Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP|X-RAY DIFFRACTION|1.8|Homo sapiens; Rattus norvegicus|0|TRANSCRIPTION","2ATH|Crystal structure of the ligand binding domain of human PPAR-gamma im complex with an agonist|X-RAY DIFFRACTION|2.28|Homo sapiens|0|TRANSCRIPTION","2F4B|Crystal structure of the ligand binding domain of human PPAR-gamma in complex with an agonist|X-RAY DIFFRACTION|2.07|Homo sapiens|0|TRANSCRIPTION ACTIVATOR","2FVJ|A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro|X-RAY DIFFRACTION|1.99|Homo sapiens|0|SIGNALING PROTEIN","2G0G|Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities|X-RAY DIFFRACTION|2.54|Homo sapiens|0|TRANSCRIPTION ACTIVATOR","2G0H|Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION ACTIVATOR","2GTK|Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION REGULATOR","2HFP|Crystal Structure of PPAR Gamma with N-sulfonyl-2-indole carboxamide ligands|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2HWQ|Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists|X-RAY DIFFRACTION|1.97|Homo sapiens|0|LIGAND BINDING PROTEIN","2HWR|Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists|X-RAY DIFFRACTION|2.34|Homo sapiens|0|LIGAND BINDING PROTEIN","2I4J|Crystal structure of the complex between PPARgamma and the agonist LT160 (ureidofibrate derivative)|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","2I4P|Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). Structure obtained from crystals of the apo-form soaked for 30 days.|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","2I4Z|Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). This structure has been obtained from crystals soaked for 6 hours.|X-RAY DIFFRACTION|2.25|Homo sapiens|0|TRANSCRIPTION","2OM9|Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSCRIPTION","2P4Y|Crystal structure of human PPAR-gamma-ligand binding domain complexed with an indole-based modulator|X-RAY DIFFRACTION|2.25|Homo sapiens|0|TRANSCRIPTION","2POB|PPARgamma Ligand binding domain complexed with a farglitazar analogue gw4709|X-RAY DIFFRACTION|2.3|Homo sapiens|0|GENE REGULATION","2PRG|LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA|X-RAY DIFFRACTION|2.3|Homo sapiens|0|COMPLEX (THIAZOLIDINEDIONE/RECEPTOR)","2Q59|Crystal Structure of PPARgamma LBD bound to full agonist MRL20|X-RAY DIFFRACTION|2.2|Homo sapiens|0|Ligand binding protein","2Q5P|Crystal Structure of PPARgamma bound to partial agonist MRL24|X-RAY DIFFRACTION|2.3|Homo sapiens|0|Ligand binding protein","2Q5S|Crystal Structure of PPARgamma bound to partial agonist nTZDpa|X-RAY DIFFRACTION|2.05|Homo sapiens|0|Ligand binding protein","2Q61|Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145|X-RAY DIFFRACTION|2.197|Homo sapiens|0|Ligand binding protein","2Q6R|Crystal structure of PPAR gamma complexed with partial agonist SF147|X-RAY DIFFRACTION|2.407|Homo sapiens|0|Ligand binding protein","2Q6S|2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides|X-RAY DIFFRACTION|2.4|Homo sapiens|0|Ligand binding protein","2Q8S|X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist|X-RAY DIFFRACTION|2.3|Homo sapiens|0|hormone receptor","2QMV|High Resolution Structure of Peroxisone Proliferation-Activated Receptor gamma and Characterisation of its Interaction with the Co-activator Transcriptional Intermediary Factor 2|SOLUTION NMR||Homo sapiens|0|transcription regulator","2VSR|hPPARgamma Ligand binding domain in complex with 9-(S)-HODE|X-RAY DIFFRACTION|2.05|HOMO SAPIENS|0|RECEPTOR","2VST|hPPARgamma Ligand binding domain in complex with 13-(S)-HODE|X-RAY DIFFRACTION|2.35|HOMO SAPIENS|0|RECEPTOR","2VV0|hPPARgamma Ligand binding domain in complex with DHA|X-RAY DIFFRACTION|2.55|HOMO SAPIENS|0|RECEPTOR","2VV1|hPPARgamma Ligand binding domain in complex with 4-HDHA|X-RAY DIFFRACTION|2.2|HOMO SAPIENS|0|RECEPTOR","2VV2|hPPARgamma Ligand binding domain in complex with 5-HEPA|X-RAY DIFFRACTION|2.75|HOMO SAPIENS|0|RECEPTOR","2VV3|hPPARgamma Ligand binding domain in complex with 4-oxoDHA|X-RAY DIFFRACTION|2.85|HOMO SAPIENS|0|RECEPTOR","2VV4|hPPARgamma Ligand binding domain in complex with 6-oxoOTE|X-RAY DIFFRACTION|2.35|HOMO SAPIENS|0|RECEPTOR","2XKW|LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE|X-RAY DIFFRACTION|2.02|HOMO SAPIENS|0|TRANSCRIPTION","2YFE|Ligand binding domain of human PPAR gamma in complex with amorfrutin 1|X-RAY DIFFRACTION|2|HOMO SAPIENS|0|RECEPTOR","2ZK0|Human peroxisome proliferator-activated receptor gamma ligand binding domain|X-RAY DIFFRACTION|2.36|Homo sapiens|0|TRANSCRIPTION","2ZK1|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2|X-RAY DIFFRACTION|2.61|Homo sapiens|0|TRANSCRIPTION","2ZK2|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with glutathion conjugated 15-deoxy-delta12,14-prostaglandin J2|X-RAY DIFFRACTION|2.26|Homo sapiens|0|TRANSCRIPTION","2ZK3|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 8-oxo-eicosatetraenoic acid|X-RAY DIFFRACTION|2.58|Homo sapiens|0|TRANSCRIPTION","2ZK4|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-oxo-eicosatetraenoic acid|X-RAY DIFFRACTION|2.57|Homo sapiens|0|TRANSCRIPTION","2ZK5|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with nitro-233|X-RAY DIFFRACTION|2.45|Homo sapiens|0|TRANSCRIPTION","2ZK6|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with C8-BODIPY|X-RAY DIFFRACTION|2.41|Homo sapiens|0|TRANSCRIPTION","2ZNO|Human PPAR gamma ligand binding domain in complex with a synthetic agonist TIPP703|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","2ZVT|Cys285Ser mutant PPARgamma ligand-binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSCRIPTION","3ADS|Human PPARgamma ligand-binding domain in complex with indomethacin|X-RAY DIFFRACTION|2.25|Homo sapiens|0|TRANSCRIPTION","3ADT|Human PPARgamma ligand-binding domain in complex with 5-hydroxy-indole acetate|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSCRIPTION","3ADU|Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate|X-RAY DIFFRACTION|2.77|Homo sapiens|0|TRANSCRIPTION","3ADV|Human PPARgamma ligand-binding domain in complex with serotonin|X-RAY DIFFRACTION|2.27|Homo sapiens|0|TRANSCRIPTION","3ADW|Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid|X-RAY DIFFRACTION|2.07|Homo sapiens|0|TRANSCRIPTION","3ADX|Human PPARgamma ligand-binding domain in complex with indomethacin and nitro-233|X-RAY DIFFRACTION|1.95|Homo sapiens|0|TRANSCRIPTION","3AN3|Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO3S|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3AN4|Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO4R|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3B0Q|Human PPAR gamma ligand binding domain in complex with MCC555|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","3B0R|Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form|X-RAY DIFFRACTION|2.15|Homo sapiens|0|TRANSCRIPTION","3B1M|Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator Cerco-A|X-RAY DIFFRACTION|1.6|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3B3K|Crystal structure of the complex between PPARgamma and the full agonist LT175|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSCRIPTION","3BC5|X-ray crystal structure of human ppar gamma with 2-(5-(3-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)-2-phenyl-2h-1,2,3-triazol-4-yl)acetic acid|X-RAY DIFFRACTION|2.27|Homo sapiens|0|TRANSCRIPTION","3CDP|Crystal structure of PPAR-gamma LBD complexed with a partial agonist, analogue of clofibric acid|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSCRIPTION","3CDS|Crystal structure of the complex between PPAR-gamma and the agonist LT248 (clofibric acid analogue)|X-RAY DIFFRACTION|2.65|Homo sapiens|0|TRANSCRIPTION","3CS8|Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|NUCLEAR PROTEIN","3CWD|Molecular recognition of nitro-fatty acids by PPAR gamma|X-RAY DIFFRACTION|2.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3D6D|Crystal Structure of the complex between PPARgamma LBD and the LT175(R-enantiomer)|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","3DZU|Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with BVT.13, 9-cis Retinoic Acid and NCOA2 Peptide|X-RAY DIFFRACTION|3.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transcription/DNA","3DZY|Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis Retinoic Acid and NCOA2 Peptide|X-RAY DIFFRACTION|3.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transcription/DNA","3E00|Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with GW9662, 9-cis Retinoic Acid and NCOA2 Peptide|X-RAY DIFFRACTION|3.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transcription/DNA","3ET0|Structure of PPARgamma with 3-(5-Methoxy-1H-indol-3-yl)-propionic acid|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","3ET3|Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid|X-RAY DIFFRACTION|1.95|Homo sapiens|0|TRANSCRIPTION","3FEJ|Design and biological evaluation of novel, balanced dual PPARa/g agonists|X-RAY DIFFRACTION|2.01|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3FUR|Crystal Structure of PPARg in complex with INT131|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/Transcription regulator","3G9E|Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/TRANSFERASE","3GBK|Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with a Potent and Selective Agonist|X-RAY DIFFRACTION|2.3|Homo sapiens|0|ligand binding protein","3H0A|Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3HO0|Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSCRIPTION","3HOD|Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","3IA6|X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist|X-RAY DIFFRACTION|2.31|Homo sapiens|0|TRANSCRIPTION","3K8S|Crystal Structure of PPARg in complex with T2384|X-RAY DIFFRACTION|2.55|Homo sapiens|0|TRANSCRIPTION","3KMG|The X-ray Crystal Structure of PPAR-gamma in Complex with an Indole Derivative Modulator, GSK538, and an SRC-1 Peptide|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3LMP|Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator|X-RAY DIFFRACTION|1.9|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3NOA|Crystal structure of human PPAR-gamma ligand binding domain complex with a potency improved agonist|X-RAY DIFFRACTION|1.98|Homo sapiens|0|TRANSCRIPTION","3OSI|Crystal structure of PPARgamma ligand binding domain in complex with tetrachloro-bisphenol A (TCBPA)|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSCRIPTION","3OSW|Crystal structure of PPARgamma ligand binding domain in complex with tetrabromo-bisphenol A (TBBPA)|X-RAY DIFFRACTION|2.55|Homo sapiens|0|TRANSCRIPTION","3PBA|Crystal structure of PPARgamma ligand binding domain in complex with monosulfate tetrabromo-bisphenol A (MonoTBBPA)|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3PO9|Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin|X-RAY DIFFRACTION|2.35|Homo sapiens|0|TRANSCRIPTION","3PRG|LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR|X-RAY DIFFRACTION|2.9|Homo sapiens|0|NUCLEAR RECEPTOR","3QT0|Revealing a steroid receptor ligand as a unique PPARgamma agonist|X-RAY DIFFRACTION|2.496|Homo sapiens|0|TRANSCRIPTION","3R5N|Crystal structure of PPARgammaLBD complexed with the agonist magnolol|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSCRIPTION/TRANSCRIPTION AGONIST","3R8A|X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity|X-RAY DIFFRACTION|2.41|Homo sapiens|0|NUCLEAR PROTEIN","3R8I|Crystal Structure of PPARgamma with an achiral ureidofibrate derivative (RT86)|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3S9S|Ligand binding domain of PPARgamma complexed with a benzimidazole partial agonist|X-RAY DIFFRACTION|2.55|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3SZ1|Human PPAR gamma ligand binding domain in complex with luteolin and myristic acid|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3T03|Crystal structure of PPAR gamma ligand binding domain in complex with a novel partial agonist GQ-16|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/TRANSCRIPTION REGULATOR"]},{"input":"P03372","source":"P03372|Estrogen receptor","targets":["1A52|ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL|X-RAY DIFFRACTION|2.8|Homo sapiens|0|RECEPTOR","1ERE|HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL|X-RAY DIFFRACTION|3.1|Homo sapiens|0|NUCLEAR RECEPTOR","1ERR|HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE|X-RAY DIFFRACTION|2.6|Homo sapiens|0|NUCLEAR RECEPTOR","1G50|CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION|X-RAY DIFFRACTION|2.9|Homo sapiens|0|DNA BINDING PROTEIN","1GWQ|HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE|X-RAY DIFFRACTION|2.45|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|NUCLEAR RECEPTOR","1GWR|HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE|X-RAY DIFFRACTION|2.4|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|NUCLEAR RECEPTOR","1HCP|DNA RECOGNITION BY THE OESTROGEN RECEPTOR: FROM SOLUTION TO THE CRYSTAL|SOLUTION NMR||Homo sapiens|0|TRANSCRIPTION REGULATION","1HCQ|THE CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR DNA-BINDING DOMAIN BOUND TO DNA: HOW RECEPTORS DISCRIMINATE BETWEEN THEIR RESPONSE ELEMENTS|X-RAY DIFFRACTION|2.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/DNA","1L2I|Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide|X-RAY DIFFRACTION|1.95|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION RECEPTOR/COACTIVATOR","1PCG|Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions|X-RAY DIFFRACTION|2.7|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/INHIBITOR","1QKT|MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL|X-RAY DIFFRACTION|2.2|HOMO SAPIENS|0|NUCLEAR RECEPTOR","1QKU|WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL|X-RAY DIFFRACTION|3.2|HOMO SAPIENS|0|NUCLEAR RECEPTOR","1R5K|Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638|X-RAY DIFFRACTION|2.7|Homo sapiens|0|DNA BINDING PROTEIN","1SJ0|Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D|X-RAY DIFFRACTION|1.9|Homo sapiens|0|HORMONE/GROWTH FACTOR RECEPTOR","1UOM|The Structure of Estrogen Receptor in Complex with a Selective and Potent Tetrahydroisochiolin Ligand.|X-RAY DIFFRACTION|2.28|HOMO SAPIENS|0|NUCLEAR PROTEIN","1X7E|CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244|X-RAY DIFFRACTION|2.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1X7R|CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1XP1|HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15|X-RAY DIFFRACTION|1.8|Homo sapiens|0|HORMONE/GROWTH FACTOR RECEPTOR","1XP6|HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16|X-RAY DIFFRACTION|1.7|Homo sapiens|0|HORMONE/GROWTH FACTOR RECEPTOR","1XP9|HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18|X-RAY DIFFRACTION|1.8|Homo sapiens|0|HORMONE/GROWTH FACTOR RECEPTOR","1XPC|HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19|X-RAY DIFFRACTION|1.6|Homo sapiens|0|HORMONE/GROWTH FACTOR RECEPTOR","1XQC|X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution|X-RAY DIFFRACTION|2.05|Homo sapiens|0|HORMONE receptor","1YIM|Human estrogen receptor alpha ligand-binding domain in complex with compound 4|X-RAY DIFFRACTION|1.9|Homo sapiens|0|HORMONE/GROWTH FACTOR RECEPTOR","1YIN|Human estrogen receptor alpha ligand-binding domain in complex with compound 3F|X-RAY DIFFRACTION|2.2|Homo sapiens|0|HORMONE/GROWTH FACTOR RECEPTOR","1ZKY|Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-3M and A Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide|X-RAY DIFFRACTION|2.25|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR RECEPTOR","2AYR|A SERM Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSCRIPTION","2B1V|Human estrogen receptor alpha ligand-binding domain in complex with OBCP-1M and a glucocorticoid receptor interacting protein 1 NR box II peptide|X-RAY DIFFRACTION|1.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR RECEPTOR","2B1Z|Human estrogen receptor alpha ligand-binding domain in complex with 17methyl-17alpha-dihydroequilenin and a glucoc interacting protein 1 NR box II peptide|X-RAY DIFFRACTION|1.78|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR RECEPTOR","2B23|Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting protein 1 NR box II peptide|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR RECEPTOR","2BJ4|ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST|X-RAY DIFFRACTION|2|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|NUCLEAR RECEPTOR","2FAI|Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-2M and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR RECEPTOR","2G44|Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-1M-G and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide|X-RAY DIFFRACTION|2.65|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR RECEPTOR","2G5O|Human estrogen receptor alpha ligand-binding domain in complex with 2-(but-1-enyl)-17beta-estradiol and a glucocorticoid receptor interacting protein 1 NR BOX II Peptide|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR RECEPTOR","2I0J|Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSCRIPTION","2IOG|Human estrogen receptor alpha ligand-binding domain in complex with compound 11F|X-RAY DIFFRACTION|1.6|Homo sapiens|0|HORMONE","2IOK|Human estrogen receptor alpha ligand-binding domain in complex with compound 1D|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","2JF9|ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST|X-RAY DIFFRACTION|2.1|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2JFA|ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE|X-RAY DIFFRACTION|2.55|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2LLO|Solution NMR-derived structure of calmodulin N-lobe bound with ER alpha peptide|SOLUTION NMR||Xenopus laevis; SYNTHETIC CONSTRUCT|0|METAL BINDING PROTEIN/HORMONE RECEPTOR","2LLQ|Solution nmr-derived structure of calmodulin c-lobe bound with er alpha peptide|SOLUTION NMR||Xenopus laevis; SYNTHETIC CONSTRUCT|0|METAL BINDING PROTEIN/HORMONE RECEPTOR","2OCF|Human estrogen receptor alpha ligand-binding domain in complex with estradiol and the E2#23 FN3 monobody|X-RAY DIFFRACTION|2.95|Homo sapiens|0|HORMONE/GROWTH FACTOR","2OUZ|Crystal Structure of Estrogen Receptor alpha-lasofoxifene complex|X-RAY DIFFRACTION|2|Homo sapiens|0|HORMONE/GROWTH FACTOR","2P15|Crystal structure of the ER alpha ligand binding domain with the agonist ortho-trifluoromethylphenylvinyl estradiol|X-RAY DIFFRACTION|1.94|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","2POG|Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relationship Studies on the Benzopyran Scaffold.|X-RAY DIFFRACTION|1.84|Homo sapiens|0|LIPID BINDING PROTEIN","2Q6J|Crystal Structure of Estrogen Receptor alpha Complexed to a B-N Substituted Ligand|X-RAY DIFFRACTION|2.7|Homo sapiens; Mus musculus|0|TRANSCRIPTION","2Q70|Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand|X-RAY DIFFRACTION|1.95|Homo sapiens|0|TRANSCRIPTION","2QA6|Crystal Structure of Estrogen Receptor Alpha mutant 537S Complexed with 4-(6-hydroxy-1H-indazol-3-yl)benzene-1,3-diol|X-RAY DIFFRACTION|2.6|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QA8|Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein|X-RAY DIFFRACTION|1.85|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QAB|Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Ethyl Indazole Compound|X-RAY DIFFRACTION|1.89|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QE4|Estrogen receptor alpha ligand-binding domain in complex with a benzopyran agonist|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","2QGT|Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound|X-RAY DIFFRACTION|2.15|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QGW|Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with a Chloro-Indazole Compound|X-RAY DIFFRACTION|2.39|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QH6|Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic diarylethylene Compound|X-RAY DIFFRACTION|2.7|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QR9|Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic Derivative Compound|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QSE|Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain complexed with Burned Meat Compound 4-OH-PhIP|X-RAY DIFFRACTION|1.85|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QXM|Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2QXS|Crystal Structure of Antagonizing Mutant 536S of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Raloxifene|X-RAY DIFFRACTION|1.7|Homo sapiens|0|TRANSCRIPTION","2QZO|Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916|X-RAY DIFFRACTION|1.72|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2R6W|Estrogen receptor alpha ligand-binding domain complexed to a SERM|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSCRIPTION","2R6Y|Estrogen receptor alpha ligand-binding domain in complex with a SERM|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSCRIPTION","2YAT|Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex|X-RAY DIFFRACTION|2.602|HOMO SAPIENS|0|TRANSCRIPTION","2YJA|Stapled Peptides binding to Estrogen Receptor alpha.|X-RAY DIFFRACTION|1.82|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR/PEPTIDE","3CBM|SET7/9-ER-AdoMet complex|X-RAY DIFFRACTION|1.69|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/TRANSFERASE RECEPTOR","3CBO|SET7/9-ER-AdoHcy complex|X-RAY DIFFRACTION|1.65|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/TRANSFERASE RECEPTOR","3CBP|Set7/9-ER-Sinefungin complex|X-RAY DIFFRACTION|1.42|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/TRANSFERASE RECEPTOR","3DT3|Human Estrogen receptor alpha LBD with GW368|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","3ERD|HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE|X-RAY DIFFRACTION|2.03|Homo sapiens|0|NUCLEAR RECEPTOR","3ERT|HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 4-HYDROXYTAMOXIFEN|X-RAY DIFFRACTION|1.9|Homo sapiens|0|NUCLEAR RECEPTOR","3HLV|Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and 16-alpha-hydroxy-estrone ((8S,9R,13S,14R,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6H-cyclopenta[a]phenanthren-17-one|X-RAY DIFFRACTION|3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3HM1|Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and estrone ((8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one)|X-RAY DIFFRACTION|2.33|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3L03|Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II peptide and Estetrol (Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol)|X-RAY DIFFRACTION|1.896|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3OS8|Estrogen Receptor|X-RAY DIFFRACTION|2.031|Homo sapiens|0|SIGNALING PROTEIN","3OS9|Estrogen Receptor|X-RAY DIFFRACTION|2.303|Homo sapiens|0|SIGNALING PROTEIN","3OSA|Estrogen Receptor|X-RAY DIFFRACTION|2.296|Homo sapiens|0|SIGNALING PROTEIN","3Q95|Crystal structure of human estrogen receptor alpha LBD in complex with GRIP peptide and estriol|X-RAY DIFFRACTION|2.05|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION REGULATOR","3UU7|Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-A|X-RAY DIFFRACTION|2.196|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","3UUA|Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-AF|X-RAY DIFFRACTION|2.05|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","3UUC|Crystal structure of hERa-LBD (wt) in complex with bisphenol-C|X-RAY DIFFRACTION|2.1|Homo sapiens|0|HORMONE RECEPTOR","3UUD|Crystal structure of hERa-LBD (Y537S) in complex with estradiol|X-RAY DIFFRACTION|1.6|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","4AA6|The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation|X-RAY DIFFRACTION|2.6|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/DNA","4DMA|Crystal structure of ERa LBD in complex with RU100132|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/protein binding/agonist","4IU7|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 2b|X-RAY DIFFRACTION|2.29|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IUI|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY derivative, 4a|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IV2|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 5a|X-RAY DIFFRACTION|2.14|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IV4|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 5b|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IVW|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b|X-RAY DIFFRACTION|2.06|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IVY|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 7a|X-RAY DIFFRACTION|1.95|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IW6|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 7b|X-RAY DIFFRACTION|1.98|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IW8|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 9a|X-RAY DIFFRACTION|2.0375|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IWC|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Thiophene-derivative|X-RAY DIFFRACTION|2.24|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IWF|Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Oxime-derivative|X-RAY DIFFRACTION|1.932|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4JC3|14-3-3 protein interaction with Estrogen Receptor Alpha provides a novel drug target interface|X-RAY DIFFRACTION|2.05|Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN/Peptide","4JDD|14-3-3 protein interaction with Estrogen Receptor Alpha provides a novel drug target interface|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN/Peptide","4MG5|Crystal structure of hERa-LBD (Y537S) in complex with chlordecone|X-RAY DIFFRACTION|2.05|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","4MG6|Crystal structure of hERa-LBD (Y537S) in complex with benzylbutylphtalate|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","4MG7|Crystal structure of hERa-LBD (Y537S) in complex with ferutinine|X-RAY DIFFRACTION|2.15|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","4MG8|Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalanol|X-RAY DIFFRACTION|1.85|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","4MG9|Crystal structure of hERa-LBD (Y537S) in complex with butylparaben|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","4MGA|Crystal structure of hERa-LBD (Y537S) in complex with 4-tert-octylphenol|X-RAY DIFFRACTION|1.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR","4MGB|Crystal structure of hERa-LBD (Y537S) in complex with TCBPA|X-RAY DIFFRACTION|1.85|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE RECEPTOR"]}]}